Skip to content Skip to sidebar Skip to footer
Infection Prevention News

Revolutionizing Infection Control: LIV Process Introduces Innovative Technology for Real-time Cleaning Verification

In an important breakthrough for infection prevention professionals in hospitals, biotechnology firm LIV Process has announced the creation of a unique microbial-visualization technology. This innovative system allows hospitals to detect contamination from pathogens like Clostridioides difficile on surfaces, facilitating real-time cleaning verification. This becomes particularly pertinent considering that CDC recognizes C. difficile as a leading…
November 20, 2025

Read more

Infection Prevention News

Clostridioides Difficile (C. diff): The Hidden Threat in Healthcare Settings

Groundbreaking research at the University of Utah has brought to light crucial information regarding the spread of Clostridioides difficile (C. diff), a common healthcare-acquired infection, purportedly spreading three times more than previously estimated. The supervising lab technician for the research, Tessa Kilberg has been pivotal in these revelations. Each year, approximately 225,000 cases of C. diff…
April 24, 2025

Read more

Infection Prevention News

Understanding Nosocomial Transmission of C. difficile: A Whole-Genome Sequencing Perspective

Nosocomial transmission of toxin-producing Clostridioides difficile presents a significant challenge for infection control professionals. This bacteria, which resides in human intestines, presents a threat in hospitals, particularly when patients and medical staff are in close quarters. Research conducted at a single center used draft whole-genome sequencing (WGS) and analysis of single nucleotide polymorphisms (SNPs) in…
September 19, 2024

Read more

Infection Prevention News

Rethinking Prevention Strategies Amidst New Findings on Clostridioides difficile In-Hospital Infections

Contrary to previous belief, the common hospital infection, Clostridioides difficile (C. Diff), is found to originate from within the patients themselves rather than via person-to-person transmission. Many hospitals grapple with effectively controlling C. Diff infections, which is particularly challenging in the intensive care units (ICUs). However, recent research indicates that the conventional belief about C.…
July 8, 2024

Read more

Infection Prevention News

Clostridioides Difficile: Unraveling the Complexities of Hospital-Onset Infections

A fresh perspective to understanding hospital-onset infections, particularly those caused by the bacterium Clostridioides difficile, better known as C. diff, was presented in a revealing study carried out by a team of researchers led by Evan Snitkin, Ph.D., Vincent Young, M.D., Ph.D., and Mary Hayden, M.D. Published in Nature Medicine, the study defies conventional beliefs…
September 21, 2023

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]